US 12,472,099 B2
Medical device and ocular implant for treatment of ocular disorders
Houfar Sekhavat, Dieppe (CA); and Nir Shoham-Hazon, Dieppe (CA)
Assigned to Hexiris Inc., Dieppe (CA)
Filed by Hexiris Inc., Dieppe (CA)
Filed on Jun. 11, 2025, as Appl. No. 19/235,272.
Application 19/235,272 is a continuation of application No. PCT/CA2023/051644, filed on Dec. 12, 2023.
Claims priority of provisional application 63/466,798, filed on May 16, 2023.
Claims priority of provisional application 63/432,270, filed on Dec. 13, 2022.
Prior Publication US 2025/0312194 A1, Oct. 9, 2025
Int. Cl. A61F 9/007 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01)
CPC A61F 9/00781 (2013.01) [A61B 2017/00367 (2013.01); A61B 2017/00477 (2013.01); A61B 17/3468 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A medical device, comprising
a) an ocular implant configured to facilitate aqueous humor outflow from an anterior chamber of an eye;
b) a piercing member for penetrating ocular tissue and housing the ocular implant prior to delivery;
c) a release structure associated with the piercing member and operable to deliver the ocular implant from the piercing member, the release structure comprising an internal casing disposed within a distal cavity of the medical device and coupled to the piercing member; and
d) an actuator operatively associated with a displacement mechanism, the displacement mechanism comprising one or more movable elements responsive to actuation and operable to engage the release structure,
wherein actuation of the actuator in a first direction causes the displacement mechanism to engage the release structure, and subsequent actuation of the actuator in a second direction causes coordinated retraction of the release structure and the piercing member to release the ocular implant from the piercing member and position the implant within the eye.